Understanding the GHRP-2 peptide

The GHRP-2 (Growth Hormone-Releasing Peptide-2) is one of the most potent stimulators of endogenous secretion of growth hormone currently known. It is an oligopeptide composed of six amino acids, capable of rapidly crossing the oral mucosa and entering the bloodstream, making it effective even when administered sublingually or buccally.

Numerous studies have shown that GHRP-2 acts directly on the pituitary gland, causing GH secretion to increase by as much as 7–15 times compared to baseline levels. In terms of potency, it is often compared to exogenous growth hormone, but with the advantage of stimulating the body’s natural production.

Thanks to its low molecular weight, GHRP-2 has high bioavailability and good tolerability. Clinical studies published as early as the 1990s confirmed its effectiveness in children, adults, and the elderly, making it one of the most studied and widely used peptides in the medical and sports fields.

---

The GHRP peptide family

The term GHRP refers to the Growth hormone-releasing peptides, a class of peptides that act as agonists of ghrelin receptors. Activation of these receptors (GHS-R1a), located in the hypothalamus and the pituitary gland, leads to a pulsatile increase in growth hormone secretion.

Early development targeted somatotropin deficiency as an alternative to GH therapy, while current uses include broader body composition and tissue repair goals.

---

How GHRP-2 works

GHRP-2 mimics ghrelin, the stomach hormone released during fasting. GHS-R1a receptor binding releases GH in a physiological and pulsatile pattern.

The increase in GH leads, in turn, to a rise in IGF-1 levels, a key protein in the processes of:

• muscle growth,

• protein synthesis,

• strengthening of tendons and bones,

• immune support,

• neuronal protection.

Exogenous growth hormone differs from GHRP-2 because GHRP-2 operates upstream through natural biological pathways.

---

Body changes from elevated GH and IGF-1

GHRP-2 alters body composition through specific hormonal shifts:

• Increase in lean body mass

• Stimulation of lipolysis and fat utilization for energy

• Improved muscle and tendon recovery

• Strengthening bone structure

• Support for collagen synthesis

Meta-analyses on healthy athletes record an average lean body mass increase of 1.8 kg alongside higher GH levels.

---

Protection for heart and cells

In addition to the effects mediated by GH and IGF-1, GHRP-2 exhibits independent properties related to its ability to bind to the CD36 receptor. Studies in animal models indicate:

• improvement in cardiac function,

• reduction of cardiac fibrosis,

• protection of cardiomyocytes during ischemic episodes,

• anti-inflammatory and antioxidant effects.

Cellular protection shields tissues against oxidative stress and hypoxia while supporting cell survival and regeneration.

---

Observed side effects

Dose-dependent side effects accompany GHRP-2 usage:

• increased appetite (due to activation of ghrelin receptors),

• increase in cortisol levels,

• increased prolactin,

• water retention,

• transient hypoglycemia.

Conscious monitoring should accompany administration.

---

Practical outcomes of GHRP-2

Primary advantages

• Strong stimulation of growth hormone

• Increase in muscle mass

• Improved body composition

• Strengthening bones and tendons

• Cardioprotective and cytoprotective properties

Possible side effects

• Increase in cortisol and prolactin

• Accentuated hunger

• Water retention

• Hypoglycemia

The GHRP-2 remains a potent peptide for GH stimulation, but responsible handling remains necessary.